Both finasteride and dutasteride fight hair loss the same way: by lowering dihydrotestosterone, the hormone that miniaturizes scalp follicles. Dutasteride suppresses more of it. That single fact drives most of the comparison, and it cuts both ways. More DHT suppression can mean more hair, and it can mean more of the side effects that come with blocking DHT. This post lays out the data on each and the logic for when, if ever, it makes sense to step up from finasteride to dutasteride.

The Mechanism, and Why the Numbers Differ

DHT is made from testosterone by an enzyme called 5-alpha-reductase, which comes in two types. Finasteride blocks type II. Dutasteride blocks both type I and type II. That broader block is why the DHT numbers are not close:

  • Finasteride lowers serum DHT by roughly 70 percent
  • Dutasteride lowers serum DHT by roughly 90 percent

Dutasteride also has a much longer half-life, on the order of weeks rather than hours, which means it builds up to steady state slowly and washes out slowly after stopping. Finasteride clears quickly. That difference matters for both the benefit and for how long side effects can linger after stopping.

Regulatory Status: This Is Not a Tie

An important asymmetry before the efficacy data. Finasteride 1 mg is FDA-approved for male pattern hair loss. Dutasteride is not. Dutasteride is approved in the US only for benign prostatic hyperplasia, and using it for hair loss is off-label. It is approved on-label for hair loss in some countries (South Korea and Japan, for example), but not in the US. The evidence base for hair loss is also considerably larger for finasteride than for dutasteride. So this is not two equal drugs; it is a well-established first-line option and a more potent off-label step-up with thinner data.

What the Head-to-Head Data Show

Despite the smaller evidence base, the comparative trials that exist favor dutasteride on raw efficacy. A randomized trial (Gubelin Harcha et al., J Am Acad Dermatol 2014), along with earlier dose-ranging work (Olsen et al. 2006), found that dutasteride 0.5 mg daily produced greater hair count improvement than finasteride 1 mg over the study periods. The greater DHT suppression appears to translate into a somewhat better hair outcome on average.

The honest caveat is that "greater on average" is not the whole story. The trials were not enormous, the follow-up was measured in months rather than years, and the long-term comparative safety data for dutasteride in hair loss are thinner than for finasteride. A bigger short-term hair benefit has to be weighed against a smaller long-term safety record and the longer washout.

The Side Effect Tradeoff

Dutasteride's side effect profile mirrors finasteride's, because both work by suppressing DHT. The categories are the same: decreased libido, erectile dysfunction, ejaculation disorders and gynecomastia. The reasonable expectation is that with more DHT suppression, these can occur somewhat more often, and several reports suggest they do.

Two points specific to dutasteride. First, the long half-life means that if a side effect appears, it can persist for weeks after stopping while the drug clears, rather than resolving quickly as finasteride often does. Second, the same mood and persistent-symptom considerations that apply to finasteride apply here. The 2025 European review that recognized suicidal ideation as a side effect covered both finasteride and dutasteride, and concluded the benefit still outweighs risk for approved uses while directing patients to stop and seek help if mood symptoms occur.

Both drugs lower PSA by roughly 50 percent, so the same screening rule applies: if you are over 40 and getting prostate screening, double your measured PSA when interpreting it. Both are contraindicated in women who are or may become pregnant and must not be handled by them. With dutasteride's long half-life, the washout precaution is longer; one common instruction is to avoid donating blood until at least six months after the last dose.

The Step-Up Logic

The standard approach is not to start with dutasteride. It is to start with finasteride, the approved, better-studied, faster-clearing option, and reserve dutasteride for specific situations.

Stepping up to dutasteride is most defensible when:

  • You have taken finasteride consistently for at least a year and your hair loss is still progressing
  • You tolerated finasteride without troubling side effects, which suggests you are likely to tolerate the same class at higher potency
  • You understand and accept the off-label status, the thinner long-term data, and the longer washout

Staying on finasteride, or not escalating, makes more sense when:

  • You are responding adequately, in which case more potency adds side-effect risk for little gain
  • You had bothersome sexual or mood side effects on finasteride, which more DHT suppression is likely to worsen, not fix
  • You are early in treatment and have not given finasteride a full 12-month trial, since the hair benefit takes that long to judge

How to Think About It

Dutasteride is the more powerful tool and, on the available comparative data, somewhat more effective for hair count. But more powerful is not automatically better. It is off-label in the US, less studied long-term, slower to leave your system, and likely to carry the DHT-related side effects at least as often as finasteride does. The sensible path for most men is finasteride first, a real 12-month trial, and a considered step up to dutasteride only if finasteride is well tolerated but no longer holding the line. That decision belongs with a clinician who knows your history.

Reviewed By

[Reviewed by: clinician name, credential. Last reviewed: date.]

Tried finasteride and wondering whether to step up? Start an intake and a licensed clinician will review your response, your tolerance and whether dutasteride makes sense for you.

This article is for education and is not a substitute for individual medical advice from your own clinician.